Posters / Best of the Best Session
Posters/Best of the Best Session submissions are now OPEN – closing on Friday 19 June 2020.
Abstract submissions for:
- Posters and
- Posters and oral presentations (Best of the Best)*
are being accepted into the 2020 meeting program.
Please submit your abstract via the online abstracts portal:
- * In addition to a Poster, your abstract may be selected as an oral presentation in the Annual Scientific Meeting Program (by invitation of the Executive Organising Committee).
- You will be able to indicate if you would like to be considered for an oral presentation during the abstracts submission process.
- Authors will be asked to record a 1-2 minute elevator pitch, to be published with their poster on-line.
- For your abstract to be accepted you must be a registered and fully paid delegate. However, you will be able to register and pay once you have been notified of your Abstract’s acceptance.
- You must consent to your abstract being published.
- Industry studies need to be presented by an AGITG clinician and have had significant involvement of the AGITG clinician.
- Encore abstracts will be accepted, provided they meet all the other criteria listed above.
- Submissions close 19 June 2020
- Abstract Authors notified 9 July 2020
Before You Start
During the abstract submission process you will be asked:
- For your name and organisation, as the presenting author.
- For your biography and photograph, as the presenting author. These will be included in the Meeting APP.
- For the name/s and organisation/s of any co-authors – to allow accurate indexing of all authors in the abstract book.
- If you wish to be considered for:
- a poster only or
- a poster and oral presentation (Best of the Best presentations are by invitation only, and made by the Executive Organising Committee, subject to available space in the Program).
- For a title for your abstract.
- For the text of your abstract – which you will be able to copy and paste in – this should be strictly no more than 350 words.
- Images and tables will not be accepted.
- Notification of programming decisions will come from the secretariat on 1st June 2020 and the working program will be posted to the web site.
- The notification will include specific presentation instructions.
- Details will be provided in due course, in regard to the format required for your digital poster.
Online Submission of Your Abstract
When you are ready to submit your abstract please click here:
Best of Posters Awards 2019
2019 Winner – Best of Posters
The winner of the 2019 Best of Posters was presented to Dr Swetha Sridharan, for ‘Palliative Oesophageal Chemoradiotherapy: A Phase I Clinical Trial. Dr Sridharan received $3,500 and a framed certificate.
2019 WINNER – FAST FORWARD
Dr Simon Wilkins was awarded the Best Fast Forward Presentation award for ‘The effect of oversewing double stapled anastomoses in oncological colorectal surgery’. Dr Wilkins receives $1,500 and a framed certificate.
The 2019 Best of Posters Award is proudly supported by GenesisCare.
Best of Posters Awards 2018
The 2018 Best of Posters Award was proudly supported by Clinical Genomics.
2018 Winner – Best of Posters
The winner of the 2018 Best of Posters was Dr Belinda Lee of Walter and Eliza Hall Institute for ‘Pancreatic Cancer: An analysis of 'Real-World' stent-related morbidity in the palliative setting’. Dr Lee received $3,500 and a framed certificate.
2018 Winner – Fast Forward
Dr Hui-Li Wong of the Walter and Eliza Hall Institute was this year’s Fast Forward winner for ‘Biomarker testing and biomarker-directed treatment utilisation for metastatic colorectal cancer in Australian practice’.
Best of Posters Awards 2017
The 2017 Best of Posters Award was proudly supported by Ipsen.
2017 Winner – Best of Posters
The winner of the 2017 Best of Posters was Dr Jennifer Mooi of the Olivia Newton-John Cancer Research Institute for ‘Exploring Consensus Molecular Subtypes (CMS) as predictors of benefit from bevacizumab in first line treatment of metastatic colorectal cancer: retrospective analysis of the MAX clinical trial’. Dr Mooi receives $3,500 and a framed certificate.
2017 Runner Up – Best of Posters
The runner-up of the Best of Posters was Dr Margaret Lee of the Walter and Eliza Hall Institute VIC for her poster and oral presentation ‘The potential of circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy decision making in locally advanced rectal cancer (LARC)’. Dr Lee receives $1,500 and a framed certificate.
2017 Winner – Fast Forward
Dr Melanie McCoy was this year’s Fast Forward winner for ‘The Cancer Stem-Like Cell Marker SOX2 is Prognostic and May Predict Response to Chemotherapy in Colon Cancer’.
Best of Posters Awards 2016
The 2016 Best of Posters Award was proudly supported by Ipsen.
2016 Winner – Best of Posters
The winner of the 2016 Best of Posters was Sharon Pattison of University of Otago for ‘Mismatch repair deficiency, inflammatory score and prognosis in gastric cancer’. The runner up was Melanie McCoy, St John of God Hospital Subiaco for ‘Immune biomarkers of response to chemoradiotherapy in locally advanced rectal cancer’.
2016 Runner Up – Best of Posters
The runner up was Melanie McCoy, St John of God Hospital Subiaco for ‘Immune biomarkers of response to chemoradiotherapy in locally advanced rectal cancer’.
Best of Posters Awards 2015
The 2015 Best of Posters Award was proudly supported by Ipsen.
2015 Winner – Best of Posters
The Posters Session continued to grow in 2015. Dr Rebecca Tay from Eastern Health was awarded the Best of Posters for her poster entitled "Survival impact of adjuvant chemotherapy for resected early stage rectal adenocarcinoma".
Best of Posters Awards 2014
The 2014 Best of Posters Award was proudly supported by Ipsen.
2014 Winner – Best of Posters
Dr Matthew Burge of Royal Brisbane Hospital won the Best Poster Award sponsored by Ipsen. Dr Burge’s poster was entitled: “A prospective, single institution study of the impact of Fluorodeoxyglucose (FDG) positron Emission Tomograpthy with concurrent non-contract CT scanning (PET/CT) on the management of operable Pancreatic, Ampullary or Distal Bile Duct cancer.”